Suraj Kalia
Stock Analyst at Oppenheimer
(3.62)
# 764
Out of 4,884 analysts
79
Total ratings
45.59%
Success rate
8.46%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $126.11 | +18.95% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $31.90 | +41.09% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $8.74 | +163.16% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $142.31 | -15.68% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $30.53 | +4.83% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $83.97 | +10.75% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $134.28 | -3.19% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.07 | +97.24% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $76.49 | +17.66% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $7.75 | +67.74% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $119.64 | +12.84% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $257.25 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $10.09 | +197.32% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.18 | +5,418.76% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $76.17 | +27.35% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.32 | +25.48% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.91 | +135.60% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.21 | +625.62% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $542.71 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.49 | +26,406.02% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $129.50 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.14 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $30.61 | +226.69% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $83.02 | - | 5 | Sep 12, 2018 |
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $126.11
Upside: +18.95%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $31.90
Upside: +41.09%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $8.74
Upside: +163.16%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $142.31
Upside: -15.68%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $30.53
Upside: +4.83%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $83.97
Upside: +10.75%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $134.28
Upside: -3.19%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.07
Upside: +97.24%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $76.49
Upside: +17.66%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $7.75
Upside: +67.74%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $119.64
Upside: +12.84%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $257.25
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $10.09
Upside: +197.32%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.18
Upside: +5,418.76%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $76.17
Upside: +27.35%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $22.32
Upside: +25.48%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.91
Upside: +135.60%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.21
Upside: +625.62%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $542.71
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.49
Upside: +26,406.02%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $129.50
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.14
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $30.61
Upside: +226.69%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $83.02
Upside: -